ask="N/A"
ask_size="N/A"
average_daily_volume="439273"
bid="16.10"
bid_size="100"
book_value="8.16"
change="+0.19"
change_from_200_day_moving_average="-0.63"
change_from_50_day_moving_average="-0.40"
change_from_52_week_high="-5.47"
change_From_52_week_low="7.50"
change_in_percent="+1.00%"
close="19.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21949000"
high="19.14"
high_52_weeks="24.57"
last_trade_date="1/27/2017"
last_trade_price="19.10"
last_trade_size="22733"
last_trade_time="4:00pm"
low="18.75"
low_52_weeks="11.60"
market_capitalization="720.68M"
moving_average_200_day="19.73"
moving_average_50_day="19.50"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="18.94"
pe_ratio="N/A"
peg_ratio="-0.72"
percent_change_from_200_day_moving_average="-3.19%"
percent_change_from_50_day_moving_average="-2.05%"
percent_change_from_52_week_high="-22.26%"
percent_change_from_52_week_low="+64.66%"
previous_close="18.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.32"
price_per_sales="5.63"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="18.30"
stock_exchange="NGM"
symbol="RTRX"
volume="314672"
weeks_range_52="11.60 - 24.57"
